IMS Health and SDI are seeking a Supreme Court review of an appeals court ruling that restricts the commercial use of prescriber data in the state of New Hampshire.
An influential advisory board urged Congress to impose far-reaching transparency rules on payments to healthcare professionals and organizations interacting with the drug industry–including reporting samples, in part to aid counterdetailing efforts.
The cuts keep coming. AstraZeneca will make another 6,000 job cuts for a total of 15,000, or 23% of its global workforce of 65,000, by 2013, and Sepracor is slashing its sales force.
Prescription Project: VNRs on YouTube are ads, must include warnings
Drug industry watchdog The Prescription Project called on FDA to take action against video news releases and B-roll for Abbott, Medtronic and Stryker medical devices appearing on YouTube, and said the agency should issue guidance for online ads.
A federal appeals court has overturned a lower court’s injunction of New Hampshire’s ban on commercial provision of prescription data, arguing that such restrictions do not constitute an abridgment of free speech.
Education and innovation were they keys to this year’s MM&M Awards in the consumer marketing and advertising categories as the judges rewarded brains over mere branding.
Effort seeks to educate faculty on promotional vs. certified CME
Reps. John Dingell and Bart Stupak (both D-MI) wrote the FDA to question its use of a pharma PR firm in developing a website about DTC advertising for consumers.
Top 20% of endocrinologists write lion’s share of new oral diabetes scripts: SDI
Identifying physicians who drive the new-to-brand market in a given category — prior to developing a marketing strategy – allows marketers to save time and money by avoiding docs with tin ears.
AI Deciphered: Discovering the Potential for Marketers and Communicators